Lower AI-measured tumour enhancement on MRI linked to earlier liver cancer return in 532 patients
Researchers analysed 532 patients with hepatocellular carcinoma who had liver surgery, split into an internal group of 372 and an external group of 160. They used artificial intelligence to automatically measure how much of the tumour enhanced on MRI in the arterial, portal venous and delayed phases.
BMC Medical Imaging
ace